These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26791140)

  • 1. Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists.
    Winpenny D; Clark M; Cawkill D
    Br J Pharmacol; 2016 Apr; 173(8):1393-403. PubMed ID: 26791140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Mol Pharmacol; 2015 Aug; 88(2):335-46. PubMed ID: 26013541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias.
    Hothersall JD; Torella R; Humphreys S; Hooley M; Brown A; McMurray G; Nickolls SA
    Neuropharmacology; 2017 May; 118():46-58. PubMed ID: 28283391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and ligand bias at the μ-opioid receptor.
    Kelly E
    Br J Pharmacol; 2013 Aug; 169(7):1430-46. PubMed ID: 23646826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine and DAMGO produce an opposite effect on presynaptic glutamate release via different downstream pathways of μ opioid receptors in the basolateral amygdala.
    Yang J; Yang H; Du X; Ma Q; Song J; Chen M; Dong Y; Ma L; Zheng P
    Neuropharmacology; 2014 Nov; 86():353-61. PubMed ID: 25196735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists.
    Dumitrascuta M; Ben Haddou T; Guerrieri E; Noha SM; Schläfer L; Schmidhammer H; Spetea M
    J Med Chem; 2017 Nov; 60(22):9407-9412. PubMed ID: 29053268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.
    Pedersen MF; Wróbel TM; Märcher-Rørsted E; Pedersen DS; Møller TC; Gabriele F; Pedersen H; Matosiuk D; Foster SR; Bouvier M; Bräuner-Osborne H
    Neuropharmacology; 2020 Apr; 166():107718. PubMed ID: 31351108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
    Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
    Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment.
    Jeong P; Kim SK; Li Q; Oh SJ; Son S; Chen G; Tan H; Kim S; Park JH; Park KD; Kim YO; Yoon MH; Kim YC; Goddard WA
    ChemMedChem; 2019 Oct; 14(20):1783-1794. PubMed ID: 31359587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.
    Brasel CM; Sawyer GW; Stevens CW
    Eur J Pharmacol; 2008 Dec; 599(1-3):36-43. PubMed ID: 18930720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling.
    Zhang X; Hutchins SD; Blough BE; Vallender EJ
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels.
    Yudin Y; Rohacs T
    Br J Pharmacol; 2019 Sep; 176(17):3110-3125. PubMed ID: 31074038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Biased View of
    Conibear AE; Kelly E
    Mol Pharmacol; 2019 Nov; 96(5):542-549. PubMed ID: 31175184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
    Knapman A; Santiago M; Connor M
    Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor.
    LaVigne J; Keresztes A; Chiem D; Streicher JM
    Pharmacol Rep; 2020 Apr; 72(2):465-471. PubMed ID: 32112361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.